drugset / Trial / NCT05697952
E1K Intra Articular(IA) Treatment for Knee Osteoarthritis
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this study is to evaluate the efficacy and safety of pain relief treatment on knee osteoarthritis when administered E1K or placebo in patients with knee osteoarthritis aged 40 to 70 to determine the optimal dose.
Timeline
- Start
- 2022-06-13
- Primary completion
- 2023-11-29
- Completion
- 2023-11-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | E1K | Unknown | 1200 ug | Other |
| Subject | E1K | Unknown | 2400 ug | Other |